Resonance Health Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Revenue	13.84	11.07	8.59	4.4	3.83	3.78
Other Revenue	-	-	-	-	0.03	-
Revenue	13.84	11.07	8.59	4.4	3.85	3.78
Revenue Growth (YoY)	31.36%	28.91%	95.02%	14.31%	1.96%	3.02%
Gross Profit	13.84	11.07	8.59	4.4	3.85	3.78
Selling, General & Admin	10.32	9.88	7.37	4.19	3.76	2.38
Research & Development	0.7	0.96	0.84	0.71	0.72	0.39
Amortization of Goodwill & Intangibles	0.5	0.52	0.26	0.3	0.31	0.29
Other Operating Expenses	0.99	0.85	0.42	0.43	0.47	0.24
Operating Expenses	12.9	12.66	9.12	5.76	5.38	3.38
Operating Income	0.94	-1.58	-0.53	-1.36	-1.52	0.4
Interest Expense	-0.33	-0.32	-0.05	-	-	-
Interest & Investment Income	0.02	0.04	0.14	0.04	0	0.04
Currency Exchange Gain (Loss)	-0.07	0.04	0.04	0.29	0.19	-0.09
Other Non Operating Income (Expenses)	-0.26	-0.3	-0.23	-0.2	-0.22	-0.01
EBT Excluding Unusual Items	0.29	-2.12	-0.63	-1.23	-1.55	0.34
Gain (Loss) on Sale of Assets	-0.08	-0.08	-	-	-	-
Asset Writedown	-	-	-	-0.03	-	-
Pretax Income	0.22	-2.2	-0.63	-1.26	-1.55	0.34
Income Tax Expense	-0.55	-0.47	-0.8	-0.48	-0.41	-0.24
Net Income	0.77	-1.73	0.17	-0.78	-1.14	0.59
Net Income to Common	0.77	-1.73	0.17	-0.78	-1.14	0.59
Shares Outstanding (Basic)	467	455	456	461	461	450
Shares Outstanding (Diluted)	474	455	468	461	461	452
Shares Change (YoY)	5.65%	-2.81%	1.59%	-	1.97%	4.59%
EPS (Basic)	0.00	-0.00	0.00	-0.00	-0.00	0.00
EPS (Diluted)	0.00	-0.00	0.00	-0.00	-0.00	0.00
Free Cash Flow	0.05	0.81	1.16	-0.45	-1.57	1.13
Free Cash Flow Per Share	-	0.00	0.00	-0.00	-0.00	0.00
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	6.77%	-14.30%	-6.16%	-30.89%	-39.57%	10.58%
Profit Margin	5.56%	-15.65%	1.97%	-17.72%	-29.63%	15.50%
Free Cash Flow Margin	0.34%	7.27%	13.48%	-10.11%	-40.86%	29.86%
EBITDA	1.12	-1.41	-0.41	-1.32	-1.49	0.42
EBITDA Margin	8.09%	-12.72%	-4.77%	-29.96%	-38.69%	11.09%
D&A For EBITDA	0.18	0.18	0.12	0.04	0.03	0.02
EBIT	0.94	-1.58	-0.53	-1.36	-1.52	0.4
EBIT Margin	6.77%	-14.30%	-6.16%	-30.89%	-39.57%	10.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.